Stable. Official website, Nanjing Jinling Pharmaceutical Factory of Jinling Pharmaceutical Co., Ltd. shows that in the first three quarters of 2023, the company achieved an operating income of 2 104 million yuan, up 2.45% year-on-year, and a net profit of 976 100 million yuan, up 5.02% year-on-year. The downstream demand for domestic medical services and pharmaceutical products has gradually recovered, and the company's medical service business has been carried out normally, and related unfavorable factors are no longer sustained.